Early clinical experience with imatinib in COVID-19: Searching for a dual effect

J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.02.002. Epub 2021 Feb 5.

Abstract

Image, graphical abstract

Publication types

  • Letter
  • Comment

MeSH terms

  • Amides
  • COVID-19*
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Pyrazines
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Amides
  • Pyrazines
  • Imatinib Mesylate
  • favipiravir